Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- Behavioral: Physical ActivityBehavioral: Nutrition CounselingBehavioral: Resistance Training
- Registration Number
- NCT06423963
- Brief Summary
The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 26
- Age 18 years or older
- Biopsy-proven pancreatic ductal adenocarcinoma (PDAC), borderline resectable at diagnosis
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Undergoing neoadjuvant chemotherapy with treatment plan including chemoradiation therapy and surgical resection
- Ability to read and speak English
- Regular engagement in RT (2x/week targeting all major muscle groups)
- Screen failure for exercise safety based on PAR-Q
- Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
- Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT
- Numeric pain rating scale greater than or equal to a 7 out of 10
- Myopathic or rheumatologic disease that impacts physical function
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Physical activity, nutrition counseling and monitoring group (PA/N) Nutrition Counseling - Physical activity, tele-resistance training, nutrition counseling and monitoring group (RT/N) Resistance Training - Physical activity, nutrition counseling and monitoring group (PA/N) Physical Activity - Physical activity, tele-resistance training, nutrition counseling and monitoring group (RT/N) Physical Activity - Physical activity, tele-resistance training, nutrition counseling and monitoring group (RT/N) Nutrition Counseling -
- Primary Outcome Measures
Name Time Method Feasibility and acceptability of PA/N and RT/N programs Up to 16 weeks The number of participants who complete T1 and T0 measures.
- Secondary Outcome Measures
Name Time Method Examine exploratory outcomes and clinical characteristics Up to 16 weeks The number of participants who demonstrate improvements in exploratory outcome measures.
Compare clinical and treatment outcomes Up to 16 weeks Chi-Square testing will be used to determine if there's a significant difference in outcomes between the treatment group and a usual care comparison group.
Trial Locations
- Locations (1)
Moffitt Cancer Center
🇺🇸Tampa, Florida, United States